Physician profile
Peter A Ricketti
NPI 1013283233
$456,622.35
in general payments reported to CMS, 2019-2025
59 companies · $190K in 2025
The $190K reported for 2025 was more than what 99% of Allergy & Immunology (Internal Medicine) providers received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2020: $1,233 · 2021: $3,687 · 2022: $51K · 2023: $77K · 2024: $132K · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $326K · Travel and Lodging: $26K · Consulting Fee: $25K · Food and Beverage: $23K · Education: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $325,531.00 |
| Travel and Lodging | $25,556.61 |
| Consulting Fee | $25,282.05 |
| Food and Beverage | $22,738.51 |
| Education | $426.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $370,762.33 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $55,253.31 | 2019-2025 | |
| Amgen INC. | $15,992.07 | 2022-2025 | Tezspire |
| Glaxosmithkline, LLC. | $4,436.03 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $3,001.30 | 2020-2025 | Takhzyro, Hyqvia, Cuvitru |
| Jazz Pharmaceuticals INC. | $807.67 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $791.38 | 2019-2025 | Dupixent |
| Csl Behring | $716.02 | 2019-2025 | Hizentra, Andembry, Haegarda |
| Genentech USA, INC. | $559.44 | 2019-2025 | Xolair |
| Grifols USA, LLC | $493.10 | 2023-2025 | Xembify, Prolastin-C Liquid |
| Optinose US, INC. | $412.37 | 2019-2025 | |
| Pfizer INC. | $397.20 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $370.04 | 2019-2025 | Spiriva Respimat, Ofev, Spiriva |
| Harmony Biosciences LLC | $212.50 | 2021-2025 | Wakix |
| Verona Pharma, INC. | $206.90 | 2025 | Ohtuvayre |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $205.34 | 2022-2025 | Adbry |
| Ars Pharmaceuticals Operations, INC. | $203.94 | 2025 | Neffy |
| Axsome Therapeutics, INC. | $128.37 | 2023-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $122.12 | 2019-2025 | |
| Covis Pharma Gmbh | $115.27 | 2021-2022 | |
| Pharming Healthcare, INC. | $107.22 | 2019-2025 | Ruconest |
| Bio Products Laboratory USA, INC. | $95.92 | 2019-2023 | Gammaplex, Coagadex |
| Philips North America LLC | $87.79 | 2019-2020 | |
| Biocryst US Sales Co., LLC | $79.98 | 2022-2025 | Orladeyo |
| Blueprint Medicines Corporation | $76.31 | 2022-2024 | Ayvakit |
| Mylan Specialty L.P. | $73.13 | 2019-2024 | Yupelri |
| Kaleo, INC. | $67.50 | 2019-2024 | Auvi-Q |
| Electromed, INC. | $54.76 | 2023-2024 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $53.21 | 2019-2022 | |
| United Therapeutics Corporation | $48.26 | 2024-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $46.42 | 2019-2024 | Arikayce |
| Gc Biopharma USA, INC. | $43.38 | 2025 | Alyglo |
| Shire North American Group INC | $41.83 | 2019 | |
| Lilly USA, LLC | $39.42 | 2025 | Ebglyss, Zepbound |
| Aimmune Therapeutics, INC. | $38.64 | 2020-2021 | |
| Galderma Laboratories, L.P. | $32.70 | 2025 | Nemluvio |
| Abbvie INC. | $31.31 | 2023-2024 | |
| Organon LLC | $31.03 | 2025 | Vtama |
| Hikma Pharmaceuticals USA | $29.50 | 2023-2024 | Ryaltris |
| Mallinckrodt Enterprises LLC | $29.32 | 2019 | |
| Greer Laboratories, INC. | $27.54 | 2024-2025 | Oralair |
| Ani Pharmaceuticals, INC. | $22.64 | 2025 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $22.27 | 2023 | |
| Sunovion Pharmaceuticals INC. | $21.85 | 2021 | |
| Inogen, INC. | $20.84 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pulmonx Corporation | $19.34 | 2022 | |
| Uswm, LLC | $19.00 | 2021 | |
| Ionis Pharmaceuticals, INC. | $18.00 | 2025 | Dawnzera |
| Baxter Healthcare | $18.00 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Adma Biomanufacturing LLC | $17.55 | 2025 | |
| Phadia US INC. | $17.39 | 2023 | Immunocap |
| Avadel Cns Pharmaceuticals, LLC | $16.73 | 2024 | Lumryz |
| Paratek Pharmaceuticals, INC. | $16.57 | 2025 | Xhance, Nuzyra |
| Azurity Pharmaceuticals, INC. | $14.94 | 2023 | Horizant |
| Alk-Abello, INC | $14.17 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.13 | 2022 | |
| Octapharma USA, INC. | $13.90 | 2021 | |
| Circassia INC. | $13.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ricketti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.